Keyphrases
Treatment Outcome
100%
Radiomics
100%
Immune Checkpoint Inhibitor Treatment
100%
Radiomic Biomarker
100%
Methodological Quality
50%
Immunotherapy Response
50%
External Validation
33%
Predictive Marker
33%
Clinical Utility
33%
Tumor
16%
Area under the Curve
16%
Feature Selection
16%
Clinical Tool
16%
Information Quality
16%
Art Performance
16%
PubMed
16%
Immune Response
16%
Data Sharing
16%
Confidence Degree
16%
Treatment Response
16%
Solid Tumors
16%
Systemic Therapy
16%
Automated Method
16%
Prospective Registration
16%
Systematic Meta-analysis
16%
Cochrane
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Tumor Cells
16%
Immune Checkpoint Inhibitors
16%
Reporting Item
16%
Meta-analysis Protocol
16%
Small number of Studies
16%
Quality Model
16%
Characteristic Model
16%
Model Performance
16%
Concordance Index
16%
Response Marker
16%
Metastatic Melanoma
16%
Multi-institutional Study
16%
Model Information
16%
Methodological Procedures
16%
Feature Dimension
16%
Protocols & Guidelines
16%
Model Calibration
16%
Therapy Types
16%
Medical Image Analysis
16%
Pantheon
16%
Dimensionality Reduction Model
16%
INIS
reviews
100%
biological markers
100%
radiomics
100%
immunotherapy
71%
validation
28%
tumors
28%
therapy
28%
performance
28%
utilities
28%
screening
14%
data
14%
patients
14%
curves
14%
values
14%
reduction
14%
cancer
14%
information
14%
tools
14%
recommendations
14%
image processing
14%
guidelines
14%
decision making
14%
metastases
14%
appraisal
14%
calibration
14%
solids
14%
lung cells
14%
tumor cells
14%
melanomas
14%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Immunotherapy
100%
Immune Checkpoint Inhibitor
100%
Neoplasm
40%
Prospective Study
20%
Non Small Cell Lung Cancer
20%
Solid Malignant Neoplasm
20%
Metastatic Melanoma
20%
Biochemistry, Genetics and Molecular Biology
Radiomics
100%
Immune Checkpoints
100%
Prospective Study
14%
Decision Making
14%
Immune Response
14%
Dimensionality Reduction
14%
Feature Extraction
14%
Neuroscience
Immunotherapy
100%
Decision-Making
20%
Meta-Analysis
20%